Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression. Khatri VM, Aboujaoude M, Karapetyan L, Tarhini AA, et al. J Neurooncol 2026;177:35.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khatri VM, Aboujaoude M, Karapetyan L, Tarhini AA, et al. Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression. J Neurooncol 2026;177:35.
PMID: 41801545